Similarly, tumor markers such as matrix metalloproteinase-9 (MMP9), stromal cell-derived factor-1α (SDF-1α), and carcinoembryonic antigen (CEA) are essential indicators of tumor progression and response to treatment [18], [19], [20]. The gene discussed is CXCL12; the disease is neoplasm.